CRYOPORT, INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (16 lists). Names and jurisdictions are as filed.
- 2026-03-05: Subsidiary Cryogene, Inc.; Jurisdiction Texas.
- 2026-03-05: Subsidiary Cryoport Systems, LLC; Jurisdiction California.
- 2026-03-05: Subsidiary MVE Biological Solutions US, LLC; Jurisdiction Delaware.
- 2026-03-05: Subsidiary Cryoport Netherlands BV; Jurisdiction The Netherlands.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-05 | Cryogene, Inc. | Texas |
| 2026-03-05 | Cryoport Systems, LLC | California |
| 2026-03-05 | MVE Biological Solutions US, LLC | Delaware |
| 2026-03-05 | Cryoport Netherlands BV | The Netherlands |
| 2026-03-05 | Cryoport France, SAS | France |
| 2026-03-05 | Cryoport Japan GK | Japan |
| 2026-03-05 | Cryoport UK Limited | United Kingdom |
| 2026-03-05 | Cryoport Belgium SA | Belgium |
| 2026-03-05 | Cryoport Germany, GmbH | Germany |
| 2026-03-05 | TEC4MED LifeScience GmbH | Germany |
| 2026-03-05 | SCI JA8 | France |
| 2026-03-05 | MVE Biological Solutions Australia Pty Limited | Australia |
| 2026-03-05 | MVE Biological Solutions Germany GmbH | Germany |
| 2026-03-05 | MVE Biological Solutions (Chengdu) Co., Ltd. | China |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |